Immunotherapy for Blood Disorders

Immunotherapy is a sort of treatment that harnesses the immune system of the patient to combat illnesses, particularly blood problems. It entails the use of medications or other substances to enhance the immune system's capacity to spot and eliminate cancer cells or other aberrant cells.

Immunotherapy has showed promise in the treatment of several malignancies, including leukaemia and lymphoma, in the area of blood disorders. Chimeric antigen receptor (CAR) T-cell treatment is one sort of immunotherapy that has been effective in treating certain blood malignancies. This entails directing a patient's own immune cells, known as T-cells, to seek out and eradicate cancer cells.
 

  • Immune Checkpoint Inhibitors in Hematologic Malignancies
  • Monoclonal Antibodies for Hematologic Malignancies
  • CAR T-Cell Therapy for Multiple Myeloma
  • Novel Approaches to Immunotherapy for Bleeding Disorders

Related Conference of Immunotherapy for Blood Disorders

February 24-25, 2025

4th European Congress on Hematology

Madrid, Spain
May 05-06, 2025

21st Global Summit on Hematology and Blood Disorders

Rome, Italy
July 07-08, 2025

23rd World Hematology Congress

Zurich, Switzerland

Immunotherapy for Blood Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in